atovaquone has been researched along with Lymphoma, B-Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Häselbarth, K; Hunfeld, KP; Krieger, G; Kurz, M | 1 |
1 other study(ies) available for atovaquone and Lymphoma, B-Cell
Article | Year |
---|---|
[Babesiosis in an immunocompromised German patient].
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimalarials; Antineoplastic Agents; Atovaquone; Azithromycin; Babesiosis; Drug Therapy, Combination; Humans; Immunologic Deficiency Syndromes; Lymphoma, B-Cell; Male; Middle Aged; Opportunistic Infections; Rituximab; Splenectomy | 2008 |